Lucie Blais
Chercheuse régulière
Hôpital du Sacré-Cœur-de-Montréal
Titulaire
Chaire pharmaceutique AstraZeneca en santé respiratoire
Professeure titulaire
Faculté de pharmacie, Université de Montréal
Lucie Blais est détentrice d’un doctorat en épidémiologie et biostatistique de l'Université McGill. Elle est professeure titulaire, vice-doyenne aux affaires professorales et secrétaire de faculté à la Faculté de pharmacie de l'Université de Montréal. Elle est chercheure au Centre de recherche de l'Hôpital du Sacré-Cœur de Montréal et chercheure associée au Centre de recherche du Centre hospitalier universitaire de Sherbrooke. Depuis 1999, Lucie Blais est co-titulaire de la Chaire de recherche Astra-Zeneca en santé respiratoire. Entre les années 2001 et 2012 elle a obtenu des bourses salariales du Fonds de Recherche du Québec – Santé (FRQS) et de l'Institut de recherche en santé du Canada (IRSC). Ses recherches portent essentiellement sur la pharmaco-épidémiologie des maladies respiratoires et sont majoritairement financées par les IRSC et le FRQS. Son programme de recherche comprend deux axes principaux, un premier sur la sécurité et l'efficacité des médicaments contre l'asthme pendant la grossesse, et le second, sur la prescription, l'utilisation, l’innocuité et l'efficacité en situation réelle des médicaments respiratoires. Elle compte à son actif plus de 150 publications scientifiques en plus de nombreuses supervisions d’étudiants aux cycles supérieurs.
Publications
8435569
Lucie Blais
1
chicago-author-date
10
date
desc
1
title
https://rechercheciusssnim.ca/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22BECZ53MK%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Blouin%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-26%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBlouin%2C%20Claudia%2C%20Am%26%23xE9%3Blie%20Forget%2C%20Lucie%20Blais%2C%20and%20Catherine%20Lemiere.%202025.%20%26%23x201C%3BResponse%20to%20IL-5%5C%2FIL-5R%20Antagonists%20and%20Remission%20Rate%20in%20Patients%20with%20Severe%20Asthma%20Who%20Would%20Have%20Been%20Excluded%20from%20the%20Pivotal%20Clinical%20Trials.%26%23x201D%3B%20%3Ci%3EThe%20Journal%20of%20Allergy%20and%20Clinical%20Immunology.%20In%20Practice%3C%5C%2Fi%3E%2C%20March%2C%20S2213-2198%2825%2900276-4.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaip.2025.03.025%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaip.2025.03.025%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Response%20to%20IL-5%5C%2FIL-5R%20antagonists%20and%20remission%20rate%20in%20patients%20with%20severe%20asthma%20who%20would%20have%20been%20excluded%20from%20the%20pivotal%20clinical%20trials.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Blouin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Lemiere%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Randomized%20controlled%20trials%20%28RCTs%29%20assessing%20the%20efficacy%20of%20Interleukin%20%28IL%29-5%5C%2FIL-5-receptor%20%28IL-5R%29%20antagonists%20showed%20a%20significant%20%20reduction%20of%20asthma%20exacerbations%20as%20well%20as%20a%20corticosteroid%20sparing%20effect%20in%20%20selected%20severe%20eosinophilic%20asthmatics.%20OBJECTIVE%3A%20To%20compare%20the%20response%20and%20%20remission%20rate%20after%20treatment%20with%20IL-5%5C%2FIL-5R%20antagonists%20in%20asthmatics%20who%20%20would%20and%20would%20not%20have%20met%20the%20inclusion%20criteria%20of%20the%20pivotal%20RCTs.%20METHODS%3A%20%20Retrospective%20cohort%20study%20of%20severe%20eosinophilic%20asthmatics%20aged%2018%20and%20older%20%20treated%20with%20IL-5%5C%2FIL-5R%20antagonists%20between%202012%20and%202020%20in%20a%20tertiary%20%20outpatient%20asthma%20clinic.%20Patients%20aged%2075%20years%20or%20younger%2C%20with%20a%20smoking%20%20history%20of%20less%20than%2010%20pack-year%2C%20and%20a%20reversible%20FEV%281%29%20%3C80%25%20predicted%20in%20the%20%20previous%20year%20were%20considered%20to%20fulfill%20the%20pivotal%20RCTs%20inclusion%20criteria.%20%20Response%20to%20treatment%20and%20clinical%20remission%20of%20asthma%20were%20assessed%20in%20those%20who%20%20did%20and%20did%20not%20fulfill%20the%20pivotal%20RCTs%20inclusion%20criteria.%20RESULTS%3A%20One%20hundred%20%20and%20eight%20subjects%20were%20included.%20Only%2022%20%2820.4%25%29%20patients%20met%20all%20the%20pivotal%20%20RCTs%20inclusion%20criteria.%20There%20was%20no%20significant%20difference%20in%20the%20response%20to%20%20treatment%20of%20these%20patients%20compared%20to%20those%20who%20did%20not%20fulfill%20the%20inclusion%20%20criteria%20%5BOR%20%2895%25%20CI%29%3A%200.66%20%280.15-2.85%29%5D.%20However%2C%20RCTs%20eligibility%20was%20%20associated%20with%20a%20higher%20likelihood%20of%20achieving%20clinical%20remission%20%5BOR%20%2895%25%20CI%29%3A%20%204.09%20%281.02-16.45%29%5D.%20CONCLUSION%3A%20IL-5%5C%2FIL-5R%20antagonists%20seem%20as%20effective%20in%20%20subjects%20who%20would%20have%20been%20excluded%20from%20the%20pivotal%20RCTs%20as%20in%20those%20who%20met%20%20the%20RCTs%20inclusion%20criteria%2C%20but%20RCTs%20eligibility%20increases%20the%20likelihood%20of%20%20achieving%20clinical%20remission%20of%20asthma.%22%2C%22date%22%3A%222025%20Mar%2026%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jaip.2025.03.025%22%2C%22ISSN%22%3A%222213-2201%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%227WZ3HMHG%22%5D%2C%22dateModified%22%3A%222025-04-08T16%3A50%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22SXQWEQ9I%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Blouin%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-26%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBlouin%2C%20Claudia%2C%20Am%26%23xE9%3Blie%20Forget%2C%20Lucie%20Blais%2C%20and%20Catherine%20Lemiere.%202025.%20%26%23x201C%3BResponse%20to%20IL-5%5C%2FIL-5R%20Antagonists%20and%20Remission%20Rate%20in%20Patients%20with%20Severe%20Asthma%20Who%20Would%20Have%20Been%20Excluded%20from%20the%20Pivotal%20Clinical%20Trials.%26%23x201D%3B%20%3Ci%3EThe%20Journal%20of%20Allergy%20and%20Clinical%20Immunology.%20In%20Practice%3C%5C%2Fi%3E%2C%20March%2C%20S2213-2198%2825%2900276-4.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaip.2025.03.025%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaip.2025.03.025%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Response%20to%20IL-5%5C%2FIL-5R%20antagonists%20and%20remission%20rate%20in%20patients%20with%20severe%20asthma%20who%20would%20have%20been%20excluded%20from%20the%20pivotal%20clinical%20trials.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Blouin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Lemiere%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Randomized%20controlled%20trials%20%28RCTs%29%20assessing%20the%20efficacy%20of%20Interleukin%20%28IL%29-5%5C%2FIL-5-receptor%20%28IL-5R%29%20antagonists%20showed%20a%20significant%20%20reduction%20of%20asthma%20exacerbations%20as%20well%20as%20a%20corticosteroid%20sparing%20effect%20in%20%20selected%20severe%20eosinophilic%20asthmatics.%20OBJECTIVE%3A%20To%20compare%20the%20response%20and%20%20remission%20rate%20after%20treatment%20with%20IL-5%5C%2FIL-5R%20antagonists%20in%20asthmatics%20who%20%20would%20and%20would%20not%20have%20met%20the%20inclusion%20criteria%20of%20the%20pivotal%20RCTs.%20METHODS%3A%20%20Retrospective%20cohort%20study%20of%20severe%20eosinophilic%20asthmatics%20aged%2018%20and%20older%20%20treated%20with%20IL-5%5C%2FIL-5R%20antagonists%20between%202012%20and%202020%20in%20a%20tertiary%20%20outpatient%20asthma%20clinic.%20Patients%20aged%2075%20years%20or%20younger%2C%20with%20a%20smoking%20%20history%20of%20less%20than%2010%20pack-year%2C%20and%20a%20reversible%20FEV%281%29%20%3C80%25%20predicted%20in%20the%20%20previous%20year%20were%20considered%20to%20fulfill%20the%20pivotal%20RCTs%20inclusion%20criteria.%20%20Response%20to%20treatment%20and%20clinical%20remission%20of%20asthma%20were%20assessed%20in%20those%20who%20%20did%20and%20did%20not%20fulfill%20the%20pivotal%20RCTs%20inclusion%20criteria.%20RESULTS%3A%20One%20hundred%20%20and%20eight%20subjects%20were%20included.%20Only%2022%20%2820.4%25%29%20patients%20met%20all%20the%20pivotal%20%20RCTs%20inclusion%20criteria.%20There%20was%20no%20significant%20difference%20in%20the%20response%20to%20%20treatment%20of%20these%20patients%20compared%20to%20those%20who%20did%20not%20fulfill%20the%20inclusion%20%20criteria%20%5BOR%20%2895%25%20CI%29%3A%200.66%20%280.15-2.85%29%5D.%20However%2C%20RCTs%20eligibility%20was%20%20associated%20with%20a%20higher%20likelihood%20of%20achieving%20clinical%20remission%20%5BOR%20%2895%25%20CI%29%3A%20%204.09%20%281.02-16.45%29%5D.%20CONCLUSION%3A%20IL-5%5C%2FIL-5R%20antagonists%20seem%20as%20effective%20in%20%20subjects%20who%20would%20have%20been%20excluded%20from%20the%20pivotal%20RCTs%20as%20in%20those%20who%20met%20%20the%20RCTs%20inclusion%20criteria%2C%20but%20RCTs%20eligibility%20increases%20the%20likelihood%20of%20%20achieving%20clinical%20remission%20of%20asthma.%22%2C%22date%22%3A%222025%20Mar%2026%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jaip.2025.03.025%22%2C%22ISSN%22%3A%222213-2201%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22K2A9NM7M%22%5D%2C%22dateModified%22%3A%222025-04-08T14%3A21%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22Y3A23986%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Godbout-Parent%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGodbout-Parent%2C%20Marim%26%23xE9%3Be%2C%20Nancy%20Julien%2C%20Hermine%20Lore%20Nguena%20Nguefack%2C%20M.%20Gabrielle%20Pag%26%23xE9%3B%2C%20Line%20Gu%26%23xE9%3Bnette%2C%20Lucie%20Blais%2C%20Sylvie%20Beaudoin%2C%20Christian%20Bertrand%2C%20and%20Ana%26%23xEF%3Bs%20Lacasse.%202024.%20%26%23x201C%3BChanging%20Society%2C%20Changing%20Research%3A%20Integrating%20Gender%20to%20Better%20Understand%20Physical%20and%20Psychological%20Treatments%20Use%20in%20Chronic%20Pain%20Management.%26%23x201D%3B%20%3Ci%3EPain%3C%5C%2Fi%3E%20165%20%283%29%3A%20674%26%23x2013%3B84.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2Fj.pain.0000000000003072%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2Fj.pain.0000000000003072%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Changing%20society%2C%20changing%20research%3A%20integrating%20gender%20to%20better%20understand%20physical%20and%20psychological%20treatments%20use%20in%20chronic%20pain%20management.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marim%5Cu00e9e%22%2C%22lastName%22%3A%22Godbout-Parent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%22%2C%22lastName%22%3A%22Julien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hermine%20Lore%22%2C%22lastName%22%3A%22Nguena%20Nguefack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Gabrielle%22%2C%22lastName%22%3A%22Pag%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Line%22%2C%22lastName%22%3A%22Gu%5Cu00e9nette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvie%22%2C%22lastName%22%3A%22Beaudoin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Bertrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%5Cu00efs%22%2C%22lastName%22%3A%22Lacasse%22%7D%5D%2C%22abstractNote%22%3A%22Treatment%20of%20chronic%20pain%20should%20be%20multimodal%20and%20include%20pharmacological%2C%20physical%2C%20and%20psychological%20treatments.%20However%2C%20because%20various%20barriers%20to%20%20physical%20and%20psychological%20treatments%20%28PPTs%29%20exist%2C%20a%20better%20understanding%20of%20%20biopsychosocial%20factors%20leading%20to%20their%20use%20is%20relevant.%20This%20study%20aimed%20to%20%20explore%20the%20association%20between%20gender%20identity%2C%20gender-stereotyped%20personality%20%20traits%2C%20and%20the%20use%20of%20PPTs%20in%20chronic%20pain%20management.%20The%20ChrOnic%20Pain%20%20trEatment%20cohort%2C%20a%20self-reported%20data%20infrastructure%20resulting%20from%20a%20web-based%20%20recruitment%20of%201935%20people%20living%20with%20chronic%20pain%20%28Quebec%2C%20Canada%29%20was%20%20analyzed.%20Gender%20identity%20was%20operationalized%20as%20women%2C%20men%2C%20and%20nonbinary.%20%20Gender-stereotyped%20personality%20traits%20were%20measured%20using%20the%20Bem%20Sex-Role%20%20Inventory%20%28feminine%2C%20masculine%2C%20androgynous%2C%20undifferentiated%29.%20A%20checklist%20of%2031%20%20types%20of%20PPTs%20that%20can%20be%20used%20for%20chronic%20pain%20management%20was%20presented%20to%20%20participants%20%28yes%5C%2Fno%29.%20From%20the%201433%20participants%2C%2085.5%25%20reported%20using%20at%20least%20%20one%20PPT.%20Hot-cold%20therapies%20%2843.4%25%29%2C%20exercise%20%2841.9%25%29%2C%20and%20meditation%20%2835.2%25%29%20%20were%20the%20most%20frequently%20used%20PPTs%2C%20but%20most%20popular%20PPTs%20were%20not%20the%20same%20among%20%20women%20and%20men.%20Women%20reported%20a%20significantly%20higher%20use%20of%20PPTs%20in%20general%20%20%2887.2%25%20vs%2077.2%25%3B%20P%20%3C%200.001%29.%20Multivariable%20and%20interaction%20analyses%20showed%20that%20%20identifying%20as%20a%20man%20decreased%20the%20odds%20of%20reporting%20the%20use%20of%20PPTs%20%28odds%20ratio%3A%20%200.32%2C%2095%25%20confidence%20interval%3A%200.11-0.92%29%20but%20only%20among%20participants%20who%20scored%20%20high%20on%20both%20masculine%20and%20feminine%20personality%20traits%20%28those%20classified%20as%20%20androgynous%29.%20The%20high%20prevalence%20of%20PPTs%20use%20found%20in%20our%20study%20is%20positive.%20Our%20%20results%20are%20relevant%20for%20a%20more%20personalized%20promotion%20of%20PPTs%20for%20chronic%20pain%20%20management.%22%2C%22date%22%3A%222024%20Mar%201%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2Fj.pain.0000000000003072%22%2C%22ISSN%22%3A%221872-6623%200304-3959%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%2238IP7QLN%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guertin%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuertin%2C%20Jason%20Robert%2C%20Naomi%20Hope%20Chouinard%2C%20Am%26%23xE9%3Blie%20Forget%2C%20and%20Lucie%20Blais.%202024.%20%26%23x201C%3BAdjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%26%23x201D%3B%20%3Ci%3EClinicoEconomics%20and%20Outcomes%20Research%3A%20CEOR%3C%5C%2Fi%3E%2016%3A675%26%23x2013%3B78.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20Robert%22%2C%22lastName%22%3A%22Guertin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%20Hope%22%2C%22lastName%22%3A%22Chouinard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2147%5C%2FCEOR.S476426%22%2C%22ISSN%22%3A%221178-6981%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IQBCKQ5T%22%5D%2C%22dateModified%22%3A%222025-04-09T17%3A55%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22MD5VCUD5%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guertin%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuertin%2C%20Jason%20Robert%2C%20Naomi%20Hope%20Chouinard%2C%20Am%26%23xE9%3Blie%20Forget%2C%20and%20Lucie%20Blais.%202024.%20%26%23x201C%3BAdjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%26%23x201D%3B%20%3Ci%3EClinicoEconomics%20and%20Outcomes%20Research%3A%20CEOR%3C%5C%2Fi%3E%2016%3A675%26%23x2013%3B78.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20Robert%22%2C%22lastName%22%3A%22Guertin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%20Hope%22%2C%22lastName%22%3A%22Chouinard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.2147%5C%2FCEOR.S476426%22%2C%22ISSN%22%3A%221178-6981%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZQ8SN4L2%22%5D%2C%22dateModified%22%3A%222025-04-09T16%3A34%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22JVK7KCHS%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guertin%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuertin%2C%20Jason%20Robert%2C%20Naomi%20Hope%20Chouinard%2C%20Am%26%23xE9%3Blie%20Forget%2C%20and%20Lucie%20Blais.%202024.%20%26%23x201C%3BAdjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%26%23x201D%3B%20%3Ci%3EClinicoEconomics%20and%20Outcomes%20Research%3A%20CEOR%3C%5C%2Fi%3E%2016%3A675%26%23x2013%3B78.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20Robert%22%2C%22lastName%22%3A%22Guertin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%20Hope%22%2C%22lastName%22%3A%22Chouinard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2147%5C%2FCEOR.S476426%22%2C%22ISSN%22%3A%221178-6981%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MH9FXHTL%22%5D%2C%22dateModified%22%3A%222025-04-09T16%3A28%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22X7Y2ZVTH%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guertin%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuertin%2C%20Jason%20Robert%2C%20Naomi%20Hope%20Chouinard%2C%20Am%26%23xE9%3Blie%20Forget%2C%20and%20Lucie%20Blais.%202024.%20%26%23x201C%3BAdjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%26%23x201D%3B%20%3Ci%3EClinicoEconomics%20and%20Outcomes%20Research%26%23x202F%3B%3A%20CEOR%3C%5C%2Fi%3E%2016%3A675%26%23x2013%3B78.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20Robert%22%2C%22lastName%22%3A%22Guertin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%20Hope%22%2C%22lastName%22%3A%22Chouinard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2147%5C%2FCEOR.S476426%22%2C%22ISSN%22%3A%221178-6981%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%227WZ3HMHG%22%5D%2C%22dateModified%22%3A%222025-04-08T16%3A50%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22AIGHKR9B%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guertin%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuertin%2C%20Jason%20Robert%2C%20Naomi%20Hope%20Chouinard%2C%20Am%26%23xE9%3Blie%20Forget%2C%20and%20Lucie%20Blais.%202024.%20%26%23x201C%3BAdjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%26%23x201D%3B%20%3Ci%3EClinicoEconomics%20and%20Outcomes%20Research%26%23x202F%3B%3A%20CEOR%3C%5C%2Fi%3E%2016%3A675%26%23x2013%3B78.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20Robert%22%2C%22lastName%22%3A%22Guertin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%20Hope%22%2C%22lastName%22%3A%22Chouinard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2147%5C%2FCEOR.S476426%22%2C%22ISSN%22%3A%221178-6981%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22K2A9NM7M%22%5D%2C%22dateModified%22%3A%222025-04-08T14%3A21%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22EM25KHSB%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guertin%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuertin%2C%20Jason%20Robert%2C%20Naomi%20Hope%20Chouinard%2C%20Am%26%23xE9%3Blie%20Forget%2C%20and%20Lucie%20Blais.%202024.%20%26%23x201C%3BAdjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%26%23x201D%3B%20%3Ci%3EClinicoEconomics%20and%20Outcomes%20Research%26%23x202F%3B%3A%20CEOR%3C%5C%2Fi%3E%2016%3A675%26%23x2013%3B78.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20Robert%22%2C%22lastName%22%3A%22Guertin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%20Hope%22%2C%22lastName%22%3A%22Chouinard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2147%5C%2FCEOR.S476426%22%2C%22ISSN%22%3A%221178-6981%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22XTEW7HZJ%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zerriouh%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EZerriouh%2C%20Meriem%2C%20Gwenaelle%20De%20Clifford-Faug%26%23xE8%3Bre%2C%20Hermine%20Lore%20Nguena%20Nguefack%2C%20M.%20Gabrielle%20Pag%26%23xE9%3B%2C%20Line%20Gu%26%23xE9%3Bnette%2C%20Lucie%20Blais%2C%20and%20Ana%26%23xEF%3Bs%20Lacasse.%202024.%20%26%23x201C%3BPain%20Relief%20and%20Associated%20Factors%3A%20A%20Cross-Sectional%20Observational%20Web-Based%20Study%20in%20a%20Quebec%20Cohort%20of%20Persons%20Living%20with%20Chronic%20Pain.%26%23x201D%3B%20%3Ci%3EFrontiers%20in%20Pain%20Research%20%28Lausanne%2C%20Switzerland%29%3C%5C%2Fi%3E%205%3A1306479.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffpain.2024.1306479%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffpain.2024.1306479%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pain%20relief%20and%20associated%20factors%3A%20a%20cross-sectional%20observational%20web-based%20study%20in%20a%20Quebec%20cohort%20of%20persons%20living%20with%20chronic%20pain.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meriem%22%2C%22lastName%22%3A%22Zerriouh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwenaelle%22%2C%22lastName%22%3A%22De%20Clifford-Faug%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hermine%20Lore%22%2C%22lastName%22%3A%22Nguena%20Nguefack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Gabrielle%22%2C%22lastName%22%3A%22Pag%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Line%22%2C%22lastName%22%3A%22Gu%5Cu00e9nette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%5Cu00efs%22%2C%22lastName%22%3A%22Lacasse%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Randomized%20clinical%20trials%20are%20used%20to%20evaluate%20the%20efficacy%20of%20various%20pain%20treatments%20individually%2C%20while%20a%20limited%20number%20of%20observational%20%20studies%20have%20portrayed%20the%20overall%20relief%20experienced%20by%20persons%20living%20with%20%20chronic%20pain.%20This%20study%20aimed%20to%20describe%20pain%20relief%20in%20real-world%20clinical%20%20settings%20and%20to%20identify%20associated%20factors.%20METHODS%3A%20This%20exploratory%20web-based%20%20cross-sectional%20study%20used%20data%20from%201%2C419%20persons%20recruited%20in%20the%20community.%20%20Overall%20pain%20relief%20brought%20by%20treatments%20used%20by%20participants%20was%20assessed%20using%20%20a%200%25-100%25%20scale%20%2810-unit%20increments%29.%20RESULTS%3A%20A%20total%20of%2018.2%25%20of%20participants%20%20reported%20minimal%20pain%20relief%20%280%25-20%25%29%2C%2060.0%25%20moderate%20to%20substantial%20pain%20relief%20%20%2830%25-60%25%29%2C%20and%2021.8%25%20extensive%20pain%20relief%20%2870%25-100%25%29.%20Multivariable%20multinomial%20%20regression%20analysis%20revealed%20factors%20significantly%20associated%20with%20greater%20pain%20%20relief%2C%20including%20reporting%20a%20stressful%20event%20as%20circumstances%20surrounding%20the%20%20onset%20of%20pain%2C%20living%20with%20pain%20for%20%5Cu226510%20years%2C%20milder%20pain%20intensity%2C%20less%20%20catastrophic%20thinking%2C%20use%20of%20prescribed%20pain%20medications%2C%20use%20of%20%20nonpharmacological%20pain%20treatments%2C%20access%20to%20a%20trusted%20healthcare%20professional%2C%20%20higher%20general%20health%20scores%2C%20and%20polypharmacy.%20Factors%20associated%20with%20lower%20%20pain%20relief%20included%20surgery%20as%20circumstances%20surrounding%20pain%20onset%2C%20use%20of%20%20over-the-counter%20pain%20medications%2C%20and%20severe%20psychological%20distress.%20DISCUSSION%3A%20%20In%20this%20community%20sample%20of%20persons%20living%20with%20chronic%20pain%2C%208%20out%20of%2010%20persons%20%20reported%20experiencing%20at%20least%20moderate%20relief%20with%20their%20treatment.%20The%20analysis%20%20has%20enabled%20us%20to%20explore%20potential%20modifiable%20factors%20as%20opportunities%20for%20%20improving%20the%20well-being%20of%20persons%20living%20with%20chronic%20pain.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffpain.2024.1306479%22%2C%22ISSN%22%3A%222673-561X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%5D%7D
Blouin, Claudia, Amélie Forget, Lucie Blais, and Catherine Lemiere. 2025. “Response to IL-5/IL-5R Antagonists and Remission Rate in Patients with Severe Asthma Who Would Have Been Excluded from the Pivotal Clinical Trials.” The Journal of Allergy and Clinical Immunology. In Practice, March, S2213-2198(25)00276-4. https://doi.org/10.1016/j.jaip.2025.03.025.
Blouin, Claudia, Amélie Forget, Lucie Blais, and Catherine Lemiere. 2025. “Response to IL-5/IL-5R Antagonists and Remission Rate in Patients with Severe Asthma Who Would Have Been Excluded from the Pivotal Clinical Trials.” The Journal of Allergy and Clinical Immunology. In Practice, March, S2213-2198(25)00276-4. https://doi.org/10.1016/j.jaip.2025.03.025.
Godbout-Parent, Marimée, Nancy Julien, Hermine Lore Nguena Nguefack, M. Gabrielle Pagé, Line Guénette, Lucie Blais, Sylvie Beaudoin, Christian Bertrand, and Anaïs Lacasse. 2024. “Changing Society, Changing Research: Integrating Gender to Better Understand Physical and Psychological Treatments Use in Chronic Pain Management.” Pain 165 (3): 674–84. https://doi.org/10.1097/j.pain.0000000000003072.
Guertin, Jason Robert, Naomi Hope Chouinard, Amélie Forget, and Lucie Blais. 2024. “Adjusting Historical Costs for Inflation with the Use of Standardized Automated Tools.” ClinicoEconomics and Outcomes Research: CEOR 16:675–78. https://doi.org/10.2147/CEOR.S476426.
Guertin, Jason Robert, Naomi Hope Chouinard, Amélie Forget, and Lucie Blais. 2024. “Adjusting Historical Costs for Inflation with the Use of Standardized Automated Tools.” ClinicoEconomics and Outcomes Research: CEOR 16:675–78. https://doi.org/10.2147/CEOR.S476426.
Guertin, Jason Robert, Naomi Hope Chouinard, Amélie Forget, and Lucie Blais. 2024. “Adjusting Historical Costs for Inflation with the Use of Standardized Automated Tools.” ClinicoEconomics and Outcomes Research: CEOR 16:675–78. https://doi.org/10.2147/CEOR.S476426.
Guertin, Jason Robert, Naomi Hope Chouinard, Amélie Forget, and Lucie Blais. 2024. “Adjusting Historical Costs for Inflation with the Use of Standardized Automated Tools.” ClinicoEconomics and Outcomes Research : CEOR 16:675–78. https://doi.org/10.2147/CEOR.S476426.
Guertin, Jason Robert, Naomi Hope Chouinard, Amélie Forget, and Lucie Blais. 2024. “Adjusting Historical Costs for Inflation with the Use of Standardized Automated Tools.” ClinicoEconomics and Outcomes Research : CEOR 16:675–78. https://doi.org/10.2147/CEOR.S476426.
Guertin, Jason Robert, Naomi Hope Chouinard, Amélie Forget, and Lucie Blais. 2024. “Adjusting Historical Costs for Inflation with the Use of Standardized Automated Tools.” ClinicoEconomics and Outcomes Research : CEOR 16:675–78. https://doi.org/10.2147/CEOR.S476426.
Zerriouh, Meriem, Gwenaelle De Clifford-Faugère, Hermine Lore Nguena Nguefack, M. Gabrielle Pagé, Line Guénette, Lucie Blais, and Anaïs Lacasse. 2024. “Pain Relief and Associated Factors: A Cross-Sectional Observational Web-Based Study in a Quebec Cohort of Persons Living with Chronic Pain.” Frontiers in Pain Research (Lausanne, Switzerland) 5:1306479. https://doi.org/10.3389/fpain.2024.1306479.
